UB Paderborn / Katalog / Suche / in CDI

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Journal of clinical oncology, 2023-12, Vol.41 (36), p.5536

2023

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1268-1274

2009

Volltextzugriff (PDF)

Role of PET in the initial staging of cutaneous malignant melanoma: systematic review

Radiology, 2008-12, Vol.249 (3), p.836

2008

Volltextzugriff (PDF)

When a metastatic breast cancer is mimicking a pancreatic cancer: case report and review of the literature

Acta clinica belgica (English ed. Online), 2020-08, Vol.75 (4), p.301-307

2020

Volltextzugriff (PDF)

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

The New England journal of medicine, 2021-09, Vol.385 (13), p.1196-1206

2021

Volltextzugriff (PDF)

Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors

Current opinion in oncology, 2022-03, Vol.34 (2), p.123

2022

Volltextzugriff (PDF)

Tamoxifen and ovarian function

PloS one, 2013-06, Vol.8 (6), p.e66616

2013

Volltextzugriff (PDF)

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

The New England journal of medicine, 2011-06, Vol.364 (26), p.2517-2526

2011

Volltextzugriff (PDF)

A Double‐Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl‐L‐Carnitine in the Prevention of Sagopilone‐Induced Peripheral Neuropathy

The oncologist (Dayton, Ohio), 2013-11, Vol.18 (11), p.1190-1191

2013

Volltextzugriff (PDF)

Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.3997-4007

2012

Volltextzugriff (PDF)

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors

Clinical cancer research, 2021-05, Vol.27 (10), p.2755-2763

2021

Volltextzugriff (PDF)

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

The New England journal of medicine, 2023-12, Vol.389 (24), p.2256-2266

2023

Volltextzugriff (PDF)

Noninvasive detection of the endogenous free radical melanin in human skin melanomas using electron paramagnetic resonance (EPR)

Free radical biology & medicine, 2022-09, Vol.190, p.226-233

2022

Volltextzugriff (PDF)

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

Clinical cancer research, 2022-06, Vol.28 (12), p.2527-2535

2022

Volltextzugriff (PDF)

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor-Positive Breast Cancer

Clinical cancer research, 2011-11, Vol.17 (21), p.6897-6904

2011

Volltextzugriff (PDF)

Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials

JAMA oncology, 2017-11, Vol.3 (11), p.1511

2017

Volltextzugriff (PDF)

Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length

Cell reports (Cambridge), 2017-06, Vol.19 (12), p.2529-2543

2017

Volltextzugriff (PDF)

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

European journal of cancer (1990), 2019-10, Vol.120, p.132-139

2019

Volltextzugriff (PDF)

Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma

Anticancer research, 2015-12, Vol.35 (12), p.6893-6899

2015

Volltextzugriff (PDF)

A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes

Clinical cancer research, 2014-04, Vol.20 (7), p.1823-1833

2014

Volltextzugriff (PDF)

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi

PloS one, 2014-10, Vol.9 (10), p.e109339-e109339

2014

Volltextzugriff (PDF)

Metabolic imaging using hyperpolarized 13 C-pyruvate to assess sensitivity to the B-Raf inhibitor vemurafenib in melanoma cells and xenografts

Journal of cellular and molecular medicine, 2020-01, Vol.24 (2), p.1934-1944

2020

Volltextzugriff (PDF)

Melanoma burden by melanoma stage: Assessment through a disease transition model

European journal of cancer (1990), 2016-01, Vol.53, p.33-41

2016

Volltextzugriff (PDF)

Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy

European journal of cancer (1990), 2016-11, Vol.67, p.38-45

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Role of PET in the initial staging of cutaneous malignant melanoma: systematic review

When a metastatic breast cancer is mimicking a pancreatic cancer: case report and review of the literature

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors

Tamoxifen and ovarian function

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

A Double‐Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl‐L‐Carnitine in the Prevention of Sagopilone‐Induced Peripheral Neuropathy

Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Noninvasive detection of the endogenous free radical melanin in human skin melanomas using electron paramagnetic resonance (EPR)

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor-Positive Breast Cancer

Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials

Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma

A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi

Metabolic imaging using hyperpolarized 13 C-pyruvate to assess sensitivity to the B-Raf inhibitor vemurafenib in melanoma cells and xenografts

Melanoma burden by melanoma stage: Assessment through a disease transition model

Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy

Aktive Filter

Suchergebnisse filtern